✦ LIBER ✦

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

✍ Scribed by Schernthaner, G.; Currie, C. J.; Schernthaner, G.-H.

Book ID: 120634081
Publisher: American Diabetes Association
Year: 2013
Tongue: English
Weight: 353 KB
Volume: 36
Category: Article
ISSN: 0149-5992
DOI: 10.2337/dcS13-2031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of anAPOC3promoter variant w

Association of anAPOC3promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

✍ M. van Hoek; T. W. van Herpt; A. Dehghan; A. Hofman; A. G. Lieverse; C. M. van D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 153 KB

## Aims/hypothesis An __APOC3__ promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether __APOC3__ polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants. ## Methods In the Rotterdam St

French medical practice in type 2 diabet

French medical practice in type 2 diabetes: The need for better control of cardiovascular risk factors

✍ C. Marant; I. Romon; S. Fosse; A. Weill; D. Simon; E. Eschwège; M. Varroud-Vial; 📂 Article 📅 2008 🏛 Masson Editeur 🌐 French ⚖ 143 KB

Oral antidiabetic treatment in type-2 di

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

✍ Peter Bramlage, Anselm K Gitt, Christiane Binz, Michael Krekler, Evelin Deeg, Di 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 279 KB

T1506: Do We Still Need Endoscopic Ultra

T1506: Do We Still Need Endoscopic Ultrasound (EUS) in the Work-up of Patients With Early Esophageal Neoplasia for Endoscopic Treatment? A Retrospective Analysis of 131 Cases

✍ Roos E. Pouw; Noor Heldoorn; Lorenza Alvarez Herrero; Fiebo J. Ten Kate; Mark I. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 119 KB

We-P11:59 The contribution of niacin for

We-P11:59 The contribution of niacin for the treatment of dislipidemia in patients with type 2 diabetes receiving combination therapy with statins

✍ Bozinovska, A.; Balalovska, L.; Bozinovski, D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 148 KB

PRODIACOR: A patient-centered treatment

PRODIACOR: A patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina: Study design and baseline data

✍ J.J. Gagliardino; S. Lapertosa; M. Villagra; J.E. Caporale; P. Oliver; C. Gonzal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 182 KB